Axsome Therapeutics, Inc. ($AXSM)
Coleman Mark โ Director
Shares
6,250
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 17, 2026
EPS:Est: -0.71
Revenue:Est: $191.33M
Feb 23, 2026
EPS:Est: -0.70
Revenue:Est: $192.82M
Transaction Details
| Insider | Coleman Mark |
|---|---|
| Title | Director |
| Transaction Date | Feb 23, 2026 |
| Exercise Date | Mar 15, 2018 |
| Expiration Date | Mar 15, 2027 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Feb 26, 2026 |
| Shares Purchased | 6,250 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 7,721 |
| Derivative | Derivative |
| Accession Number | 0001193125-26-072481 |
| Document | View SEC Filing |